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An Industry Perspective on the Benefits of and
Regulation of Genetically Engineered Plants
NICHOLAS M. FREY
Pioneer Hi-Bred International, Inc., P.O. Box 85, Johnston, Iowa 50131
The seed industry has routinely incorporated new technology into its research and development programs. Plant generic engineering is
the most recent technology to be utilized for seed product development efforts. New sources of herbicide, insect, and disease resistance are
being incorporated into crop plants using cellular and molecular biology techniques.
New regulatory guidelines have been developed which require regulatory approval before genetically engineered plants can be reseed in
the field and ultimately marketed. The impact of these regulations on product development is unclear. Hopefully a dialogue will develop
among industry, government agencies, and the public such that reasonable and appropriate regulatory procedures evolve. Those
procedures need to facilitate the development of beneficial plant products while assuring the public that safety and environmental risks
are acceptable.
INDEX DESCRIPTORS: Plant genetic engineering, seeds, regulations.

Future seed product development will draw upon the techniques of
plant genetic engineering to add useful new traits to our crop plants.
Plants with improved resistance to herbicides and with resistance to
lepidopteran insect pests are now in the early stages of product
development. Crop production will benefit increasingly from biological controls of disease and insect pests as a result of recent laboratory
advances in cellular and molecular biology.
Industry's objective in investing in research, including genetic
engineering technologies, is to develop useful new products to sell.
The prospects for plant genetic engineering have drawn increasing
attention from the USDA, EPA, and FDA despite the historically
minimal regulatory oversight in seed product development. Regulatory requirements can greatly impact the development of seed
products that have been improved through genetic engineering.
Increasing dialogue among industry, government, and the public is
needed to ensure that reasonable regulatory procedures develop.
American industry and American agriculture must remain competitive in a world economy. Regulation of seed product development
must balance the economic and environmental benefits and the risks
associated with genetically engineered plants.
The objectives for this paper include describing seed product
development, providing examples of traits likely to be added to our
crop plants using genetic engineering technologies, and discussing
concerns I have about regulatory oversight. Regulatory policies must
recognize the public's interest for environmental safety while not
unreasonably constraining the commercialization of molecular genetic
technology that will benefit agricultural producers and consumers.

PRODUCT TESTING AS A
PART OF PRODUCT DEVELOPMENT
Testing new products to identify those suitable for market introduction and commercial use is an essential component of any wellmanaged product development effort. The same is true for products
developed through molecular biology or genetic engineering as it is
for products developed through existing or conventional technologies.
Successful companies are those who effectively utilize available technology to develop new and useful products for their customers.
Research-based companies also invest in technology development as well
as technology application with the assumption that the added cost and
risk of technology development will be rewarded when new technology is effectively delivered to the market. Hewlett-Packard, 3M, and
Xerox are companies that have successfully delivered technology to
the market and they have been rewarded for that. The domestic steel
and auto industries are examples of industries that failed to stay on the

leading edge of technology development.

DEVELOPMENT OF HERBICIDE
RESISTANT CORN HYBRIDS
I will give you some examples of new technologies that are being
developed to enhance performance of future seed products. Pioneer is
currently developing herbicide-resistant corn. The trait was developed for American Cyanamid by Molecular Genetics Incorporated
using tissue culture selection. Since genetic engineering was not used,
our product development has not been restricted by the regulatory
framework. Nevertheless, genetically engineered herbicide resistance
will be one of the first commercial developments from biotechnology.
Critics have stated herbicide-resistant crops are undesirable because
they will increase usage of herbicides and thereby exacerbate ground
water contamination problems. Are such criticisms valid? I think not.
More than 95% of the corn acreage is now treated with herbicide.
Herbicide-resistant corn will not likely change the percentage of
treated acres. Furthermore, the herbicide resistance is to a new family
of herbicides that requires very low use races compared to herbicides
currently used on corn. Two to four o-dA (140-240 g/ha) of these new
imidazolinone herbicides will provide weed control similar to that
achieved by 2 to 6 lbs/ A (2. 2 to 6. 7 kg/ha) of existing corn herbicides.
The 16-fold decrease in chemical applied to the soil offers a sound
environmental advantage where ground water contamination issues
are real concerns. The new herbicides have a performance advantage
on problem weeds such as shattercane and wild proso millet. Furthermore, the chemicals possess very low mammalian toxicities compared
to many existing chemicals. I believe that the benefits of this new
technology clearly outweigh the risks. The commercial acceptance of
this technology will depend, however, on the economic return
achieved by rhe farmer ifhe chooses to use this new technology instead
of his existing technology.

POTENTIAL FOR INSECT RESISTANCE
USING BIOTECHNOLOGY
Biological control of pests whether insect or disease remains an
elusive, but desirable, commercial business. Plant breeders have
likely been the most effective developers of commercially viable
biological control. Crop plants with resistance to one or more diseases
are common. Insect resistance has been more difficult to accomplish,
but there are some notable successes. Those include Hessian Fly
resistance in wheat, greenbug tolerance in sorghum, and pea and blue
aphid tolerance in alfalfa. Biological control in general has an efficacy
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ranging from zero to perhaps 70 or 85%, depending on the pest
pressure and the weather. Biological insecticides such as Dipel or
Thuricide have such efficacies. These insecticides utilize a bacteria,
Bacillm thuringiemis. The bacteria produces a protein crystal, i.e., the
Be toxin, that is toxic ro certain insects when ingested. The products
are widely used in home gardens to control cabbage loopers and
tomato hornworms. The biologic insecticides are also used in stored
grain for Indian meal moth control. The Bacillus insecticide has very
short residual activity when exposed to ultraviolet light, and thus
repeated applications at perhaps 3-day intervals are required for
sustained insect control. The produces have not been very successful
for European corn borer control in corn because of this short efficacy
period and the expense of repeated applications. Molecular biologists
have cloned the gene for Br toxin from Bacillus thuringiemis and have
inserted the bacterial toxin gene into plants. The Be protein is
produced in plant leaves at levels sufficient to make the plants insect
resistant. Be toxin is not toxic to mammals, including humans.
Insects have an alkaline gut that breaks the Be protein into a
component toxic to the insect. The Be protein is simply digested
without harmful effect in mammals which have an acid gut. Genetic
engineering may make biological control commercially viable where
it has had limited success ro date.
Making biological control competitive with chemical control
seems a worthy goal to pursue. The American consumer has demanded consistent insect control in our fruit and vegetable products. Only
chemical insecticides have provided the necessary level of insect
control. If genetic engineering improves plant insect resistance, for
example by producing Br toxin that is stable when exposed to
sunlight, biological control may displace some chemical controls.
That could enhance profitability to producers and offer desirable
environmental benefits as well.
NECESSI1Y OF GENETIC ENGINEERING
IN REMAINING COMPETITIVE
Pioneer Hi-Bred International is a research-based company, and we
plan to use available technology to develop useful, new seed products
for our customers. That includes using genetic engineering technology co introduce new, desirable genes or traits into plants. We must use
genetic engineering technology as aggressively as we have used the
computer or other technologies to enhance ou~ product development
if we are to remain competitive in the genetIC supply busmess. To
ignore technology due to regulatory uncertainty, due to a poorly
informed public's concern over safety of the technology, or due to our
unwillingness to risk the research investment is to renege on our
commitment to deliver superior seed products to our customers. We
must compete in the international arena of seed product development
if we are to survive as a company and if we are to deliver seed products
to our customers that will maximize their profitabililty. It is from this
perspective that Pioneer views testing and marketing geneti~ally
engineered plants. This perspective is likely _shared by _most agr~cul
tural companies developing genetically engmeered mICroorgamsms
and animal products. I think it should be a perspewve shared by
fu.rmers who realize how critical being the low-cost producer of
agricultural commodities is to their survival in t~ay's worl~ ec~nomy.
It is a perspective our steel and auto producers failed to mam~am,_ and
they are struggling to regain their competitiveness and profoab1ltty.
CONCERNS ABOUT REGULATORY COSTS
FOR PRODUCT DEVELOPMENT USING
GENETIC ENGINEERING
That pragmatic view of the utility of genetic engineering might
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suggest that Pioneer or perhaps industry in general should pursue chis
new technology without regard for public safery or the environment.
Clearly that cannot and will not be done. But what risk does genetic
engineering technology pose? Newspaper accounts, ofren reporting
scientists' claims or testimony before congressional committees,
convey the message that genetic engineering technology is both
powerful and useful. Others, including critics of the technology, point
out risks they perceive from genetic engineering. The regulatory
framework published in the June 26, 1986, Federal Register demonstrates the concern of the regulatory agencies who are charged with
protecting the public health and welfare. I am not here to tell you that
there are no risks associated with genetic engineering technology.
There are risks associated with any new technology. There are also
benefits. Pioneer is anxious to exploit the benefits of genetic engineering technology. We want to do so prudently such that benefits clearly
ourweigh risks. I feel the industry, the general public, and the
government must work together to consider the risks and the benefits
of applying genetic engineering to improve the efficiency of our
agriculture, to diversify our agricultural production, to improve
human health, co improve animal health, and to improve biological
processing. Regulatory oversight is needed as we develop the technology. Yet chat oversight must be consistent with the risks that are likely
to be encountered, and quite frankly, consistent with the profit
potential of a given product. If expenses to gain regulatory approval
exceed the profit potential of the finished product, there will be no
new product developed by the private sector.
I am concerned that the regulatory requirements currently being
implemented may prove co be overly restrictive. How the various
agencies will interpret and implement the regulations are not fully
known. Pioneer and other companies have provided input to governmental agencies as the rules were developed. The industry has
recognized the need for reasonable regulations. We have also recommended chat provisions be made to relax the regulatory requirements
as experience suggests such relaxation is warranted. The_ C1;1frent
regulations may be sufficiently burdensome to severely limit the
development of the technology for the good of American agricult'.-1re,
the good of American business, and yes, the good of t~e Amencan
public. We get mixed signals from the regulatory agei:ines, ~d that
will likely continue until the coordinated framew?rk _is fully _implemented. This regulatory uncertainty poses some s1g01ficant nsks for
industry. An example may help make the point chat products can be
regulated out of the market. Let's assume chat genetic engii:ieering of
soybeans and wheat is possible, and we have a gene that will control
cyst nematode of soybean and one that will control Russian _wh~t
aphid in wheat. Let's also assume each variety with the new trait will
be treated as a new pesticide under the regulatory framework. Expense
to meet USDA/EPA requirements for field testing will be several
thousand dollars unless long-term animal toxicology studies are
required. That will be an agency decision. The costs would then
escalate to $1 to 2 million. Alternatively, if FDA feels a gene chat
enhances lysine content of cereal proteins must be considere~ ~food
additive FDA food additive approvals can cost over $10 million. If
regulato~ costs approach $1 million or more ~or a single seed variety,
it is unlikely that a seedsman can afford to deliver that l?r~uct to the
market. Pioneer has had few if any soybean or wheat var1et1es generate
$1-2 million in profit before being replaced by a new variety. In fact,
total net contribution over the past 5 years for Pioneer's entire soybean
product line has been $7.5 million, and Pioi:ieer's wheat p~uct _line
has lost $4.4 million for the same 5-year penod. Those conmbut1ons
are before indirect costs and tax payments are removed. How much
regulatory expense can these self-pollinated crops ~ord? Do w_e want
more effective biological control of insects and disease pest m selfpollinated crops?
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BALANCING REGULATORY COSTS
AND PRODUCT BENEFITS
How can we keep regulatory costs low while providing for public
safery? We must find an answer to that question if com~ies are to
deliver genetic engineering technology co the market ~d 1f we _are ~o
rely more heavily on biological control in crop produc~10n. This will
require industry, government, and the general public to work together to assess the risks and the benefits of the technology, and to
implement regulations that support the development of the technology while not threatening public welfare. le is urgent chat we begin
developing the experience we need to identify the real versus perceived
risks of the technology. It is also urgent for us to examine our
experiences in field testing conventional produces as chose experiences
may predict risks associated with products developed using these
newer technologies. Small-scale field tests of genetically engineered

planes in an isolated location where the planes are not all?wed to si:c
seed will not provide much valuable experience, yet that 1s all chat ~s
being allowed today. Furthermore, it is not clear how to gee from this
initial field test to a commercial product which can be sold to a farmer.
Clearly more work has to be done. The work can only be done if we
avoid being adversaries and instead decide we must answer the
questions together. We need to lay all the problems on the cable and
decide which are real and which are perceived. We need to share
relevant data and experiences that are pertinent to risk assessment.
Relevant data do exist. Then we can work co solve the real problems,
ensuring chat benefits to society are weighed along with risks.
Mistakes may be made, but under reasonable guidelines potential
harm will be minimized and the information gained more valuable
than if no experience were gained. The mistake I fear most is that we
will be so cautious that beneficial produces are denied society. Of
course we cannot put a price on what could have been unless a
competitor, either domestic or foreign, succeeds at our expense.

